Calculation of electron dose to target cells in a complex environment by Monte Carlo code “CELLDOSE”

BackgroundWe used the Monte Carlo code “CELLDOSE” to assess the dose received by specific target cells from electron emissions in a complex environment. 131I in a simulated thyroid was used as a model.MethodsThyroid follicles were represented by 170 μm diameter spherical units made of a lumen of 150 μm diameter containing colloidal matter and a peripheral layer of 10 μm thick thyroid cells. Neighbouring follicles are 4 μm apart. 131I was assumed to be homogeneously distributed in the lumen and absent in cells. We firstly assessed electron dose distribution in a single follicle. Then, we expanded the simulation by progressively adding neighbouring layers of follicles, so to reassess the electron dose to this single follicle implemented with the contribution of the added layers.ResultsElectron dose gradient around a point source showed that the 131I electron dose is close to zero after 2,100 μm. Therefore, we studied all contributions to the central follicle deriving from follicles within 12 orders of neighbourhood (15,624 follicles surrounding the central follicle). The dose to colloid of the single follicle was twice as high as the dose to thyroid cells. Even when all neighbours were taken into account, the dose in the central follicle remained heterogeneous. For a 1-Gy average dose to tissue, the dose to colloidal matter was 1.168 Gy, the dose to thyroid cells was 0.982 Gy, and the dose to the inter-follicular tissue was 0.895 Gy. Analysis of the different contributions to thyroid cell dose showed that 17.3% of the dose derived from the colloidal matter of their own follicle, while the remaining 82.7% was delivered by the surrounding follicles. On the basis of these data, it is shown that when different follicles contain different concentrations of 131I, the impact in terms of cell dose heterogeneity can be important.ConclusionBy means of 131I in the thyroid as a theoretical model, we showed how a Monte Carlo code can be used to map electron dose deposit and build up the dose to target cells in a complex multi-source environment. This approach can be of considerable interest for comparing different radiopharmaceuticals as therapy agents in oncology.

[1]  L. Ricci-Vitiani,et al.  Colon cancer stem cells , 2007, Gut.

[2]  E. Hindié,et al.  Microscopic distribution of iodine radioisotopes in the thyroid of the iodine deficient new-born rat: insight concerning the Chernobyl accident. , 2001, Cellular and Molecular Biology.

[3]  Christophe Champion,et al.  CELLDOSE: A Monte Carlo Code to Assess Electron Dose Distribution—S Values for 131I in Spheres of Various Sizes , 2007, Journal of Nuclear Medicine.

[4]  S. H. Wollman,et al.  Distribution of organic 125-I and 127-I in the rat thyroid gland during equilibrium labeling as determined by autoradiography. , 1967, Endocrinology.

[5]  Wei Bo Li,et al.  Track Structures and Dose Distributions from Decays of 131I and 125I in and around Water Spheres Simulating Micrometastases of Differentiated Thyroid Cancer , 2001, Radiation research.

[6]  George Sgouros,et al.  Dosimetry of internal emitters. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Chatal,et al.  Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres. , 1994, Physics in medicine and biology.

[8]  B. Wessels,et al.  MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  E. Hindié,et al.  Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA , 2005 .

[10]  C. Champion,et al.  Theoretical cross sections for electron collisions in water: structure of electron tracks , 2003, Physics in medicine and biology.

[11]  W. V. Prestwich,et al.  Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Douglas Benson,et al.  High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometry , 2006, Journal of biology.

[13]  Bernard Basse-Cathalinat,et al.  Recent technologic developments on high-resolution beta imaging systems for quantitative autoradiography and double labeling applications , 2004 .

[14]  Roger W Howell,et al.  Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  S. Korenman Williams Textbook of Endocrinology; Williams Textbook of Endocrinology CD-ROM , 2003 .

[16]  K. Kopecky,et al.  Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. , 2003, International journal of epidemiology.

[17]  S. Adelstein,et al.  Radiobiologic principles in radionuclide therapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  E. Hindié,et al.  Non-medical exposure to radioiodines and thyroid cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  S. Goddu,et al.  Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  S. H. Wollman,et al.  Distribution of Organic 125I and 127I in the Rat Thyroid Gland During Equilibrium Labeling as Determined by Autoradiography1 , 1967 .

[21]  S. Nagataki,et al.  Prevalence of goiter and urinary iodine excretion levels in children around Chernobyl. , 1997, The Journal of clinical endocrinology and metabolism.

[22]  H. Lundqvist,et al.  Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies. , 2000, International journal of radiation oncology, biology, physics.

[23]  G. Brabant,et al.  Radiation-induced thyroid carcinogenesis as a function of time and dietary iodine supply: an in vivo model of tumorigenesis in the rat. , 2002, Endocrinology.

[24]  A. Purushotham,et al.  Stem cells and breast cancer , 2007, Histopathology.

[25]  W E Bolch,et al.  MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  George Sgouros,et al.  MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  K. Baverstock,et al.  Iodine deficiency in Belarusian children as a possible factor stimulating the irradiation of the thyroid gland during the Chernobyl catastrophe. , 1997, Environmental health perspectives.

[28]  S. Goddu,et al.  Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Kostas Kostarelos,et al.  Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread. , 2007, Cancer biotherapy & radiopharmaceuticals.

[30]  W G Cross,et al.  Beta-ray dose distributions from point sources in an infinite water medium. , 1992, Health physics.

[31]  W. Stumpf Drug localization and targeting with receptor microscopic autoradiography. , 2005, Journal of pharmacological and toxicological methods.

[32]  Elisabeth Cardis,et al.  Risk of thyroid cancer after exposure to 131I in childhood. , 2005, Journal of the National Cancer Institute.

[33]  M. Puncher,et al.  Radionuclide targeting and dosimetry at the microscopic level: the role of microautoradiography , 1994, European Journal of Nuclear Medicine.

[34]  A. D. Dunn,et al.  Update on intrathyroidal iodine metabolism. , 2001, Thyroid : official journal of the American Thyroid Association.

[35]  P. Zanzonico,et al.  Age-dependent thyroid absorbed doses for radiobiologically significant radioisotopes of iodine. , 2000, Health physics.